Synaptics Incorporated
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.0% | -1.3% | +11.2% | -1.2% | -9.4% | +1.1% | +1.2% | -0.3% | -0.5% | -1.6% | -16.7% | |
| – | +3.5% | -2.2% | +3.5% | -1.9% | -21.9% | -20.0% | +5.5% | -0.4% | +2.9% | -2.0% | +4.2% | |
| – | +5.6% | -2.1% | +5.9% | -2.7% | -30.2% | -39.5% | +8.6% | +17.5% | -4.9% | -12.3% | +15.3% | |
| – | +2.9% | -2.4% | +5.8% | -2.7% | -30.2% | -29.3% | +7.4% | +1.6% | -4.9% | -7.5% | +9.4% | |
| – | +7.0% | +14.2% | -1.6% | -5.4% | +7.9% | -9.1% | -2.2% | -8.3% | +11.0% | +22.5% | +0.9% | |
| – | -5.0% | -8.8% | -0.1% | +4.9% | -0.1% | +11.2% | +5.0% | +2.6% | +10.4% | +2.1% | -3.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.4% | +6.4% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -6.3% | +36.4% | -21.8% | +6.2% | -7.1% | +53.1% | -7.8% | -8.8% | -35.7% | -11.0% | -10.4% | |
| – | +0.6% | -3.6% | +4.1% | -2.5% | -13.0% | +1.4% | +1.9% | -1.1% | +0.3% | -1.3% | +0.8% | |
| – | +3.2% | -16.7% | +31.4% | -8.4% | -9.5% | +7.7% | +9.5% | -3.3% | +0.5% | -5.8% | +182.6% | |
| – | +2.0% | +1.3% | +299.4% | -72.4% | -33.9% | +2.7% | +291.4% | -75.1% | – | – | +4,047.2% | |
| – | +29.9% | -14.6% | +23.4% | -4.8% | +0.8% | +7.1% | +9.4% | -6.1% | +3.5% | -18.8% | +6.3% | |
| – | -0.1% | -0.1% | -0.1% | -0.1% | -13.8% | +0.2% | +0.1% | +0.1% | +0.1% | +0.1% | -52.5% | |
| – | +1.3% | +1.2% | +18.7% | +0.0% | -6.2% | +0.8% | +0.6% | +0.4% | -1.2% | -1.8% | -31.6% | |
| – | -0.9% | -1.7% | +20.2% | -1.9% | +0.1% | -1.8% | -0.4% | -1.7% | -1.3% | -0.7% | -39.0% | |
| – | +1.0% | +0.3% | +1.5% | +0.0% | -0.3% | -2.0% | -1.0% | +1.8% | -1.0% | -0.3% | +0.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.